Page last updated: 2024-08-23

lovastatin and Congenital Ichthyosiform Erythroderma

lovastatin has been researched along with Congenital Ichthyosiform Erythroderma in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's0 (0.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abbas, O; Abdallah, B; Bergqvist, C; Hamie, L; Hasbani, DJ; Kibbi, AG; Kurban, M; Rubeiz, N1
Machado, MCR; Nico, MMS; Oliveira, ZNP; Sandoval, KR1
Cabrera, AN; Crumrine, D; Elias, PM; Heath, C; Paller, AS; Rodriguez-Martín, M; Sorrell, J; van Geel, M; van Steensel, MA1
Williams, ML1

Reviews

1 review(s) available for lovastatin and Congenital Ichthyosiform Erythroderma

ArticleYear
Epidermal lipids and scaling diseases of the skin.
    Seminars in dermatology, 1992, Volume: 11, Issue:2

    Topics: Animals; Anticholesteremic Agents; Cholesterol Esters; Epidermis; Fatty Acids, Essential; Humans; Ichthyosiform Erythroderma, Congenital; Ichthyosis, X-Linked; Lipid Metabolism; Lipids; Lovastatin; Skin Diseases

1992

Other Studies

3 other study(ies) available for lovastatin and Congenital Ichthyosiform Erythroderma

ArticleYear
CHILD syndrome: A modified pathogenesis-targeted therapeutic approach.
    American journal of medical genetics. Part A, 2018, Volume: 176, Issue:3

    Topics: 3-Hydroxysteroid Dehydrogenases; Abnormalities, Multiple; Biopsy; Child; Cholesterol; Female; Genetic Diseases, X-Linked; Humans; Ichthyosiform Erythroderma, Congenital; Limb Deformities, Congenital; Lovastatin; Mutation; Phenotype; Skin; Treatment Outcome

2018
CHILD syndrome: successful treatment of skin lesions with topical lovastatin and cholesterol lotion.
    Anais brasileiros de dermatologia, 2019, 07-26, Volume: 94, Issue:3

    Topics: Abnormalities, Multiple; Administration, Topical; Anticholesteremic Agents; Cholesterol; Female; Genetic Diseases, X-Linked; Humans; Ichthyosiform Erythroderma, Congenital; Infant; Limb Deformities, Congenital; Lovastatin; Metabolic Diseases

2019
Pathogenesis-based therapy reverses cutaneous abnormalities in an inherited disorder of distal cholesterol metabolism.
    The Journal of investigative dermatology, 2011, Volume: 131, Issue:11

    Topics: Administration, Topical; Adolescent; Cholesterol; Drug Therapy, Combination; Female; Humans; Ichthyosiform Erythroderma, Congenital; Limb Deformities, Congenital; Lipid Metabolism; Lovastatin; Metabolic Diseases; Phenotype; Skin; Skin Abnormalities; Syndrome; Treatment Outcome; Young Adult

2011